3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis

Peritoneal Dialysis International

Volumn 18, Issue 3, 1998, Pages 290-293

  Linden, Torbjörn ^a   Forsbäck, Gunita ^a   Deppisch, Reinhold ^b   Henle, Thomas ^b   Wieslander, Anders ^a  

^a Gambro AB   (Sweden)

^b Gambro AB Research and Development   (Germany)

Author keywords

3 Deoxy D erythro hexos 2 ulose; 3 Deoxyglucosone; Advanced glycation end products; AGE; Analysis of peritoneal dialysis fluids; Glucose degradation products; HPLC

Indexed keywords

3 DEOXYGLUCOSONE; CARBONYL DERIVATIVE; DEOXYGLUCOSE; NAPHTHALENE DERIVATIVE; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG;

ARTICLE; CROSS LINKING; GLUCOSE METABOLISM; GLYCATION; GLYCOSYLATION; HEATING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; ULTRAFILTRATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGLUCOSE; DIALYSIS SOLUTIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HEAT; HUMANS; STERILIZATION;

EID: 0031880765     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cerami A, Vlassara H, Brownlee M. Glucose and aging. Sci Am 1987; 256(5):90-6.
2. Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995; 26(6):875-88.
3. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, et al. Advanced glycation end products and their receptors in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997; 40:619-28.
4. Chappey O, Dosquet C, Wautier M-P, Wautier J-L. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 1997; 27:97-108.
5. Dobbie JW. Advanced glycosylation end products in peritoneal tissue with different solutions. Perit Dial Int 1997; 17:27-30.
6. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in the peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in CAPD. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:3-12.
7. Dobbie JW. Pathogenesis of peritoneal fibrosing syndrome (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
8. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
9. Lamb EJ, Cattell WR, Dawnay ABStJ. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47:1768-74.
10. Dawnay ABStJ, Millar DJ. Glycation and advanced glycation end-products formation with icodextrin and dextrose. Perit Dial Int 1997; 17:52-8.
11. Dawnay ABStJ, Wieslander A, Millar DJ. In vitro advanced glycation end-product formations reduced in PD fluid heat sterilized in two-compartment bags (Abstract). J Am Soc Nephrol 1996; 7:1477.
12. Wieslander A, Nordin MK, Kjellstrand PT, Boberg U. Toxicity of peritoneal dialysis fluids on cultured fibroblasts L-929. Kidney Int 1991; 40:77-9.
13. Nilsson-Thorell C, Muscalu N, Andrén AHG, Kjellstrand P, Wieslander A. The heat sterilization of fluids for peritoneal dialysis gives rise to several aldehydes. Perit Dial Int 1993; 13:208-13.
14. Henderson IS, Couper IA, Lumsden A. Potentially irritant glucose metabolites in unused CAPD fluid. In: Winchester JF, ed. Frontiers in peritoneal dialysis. New York: Field, Rich and Associates, 1986:261-4.
15. Henderson IS, Couper IA, and Lumsden A. The effect of shelf life of peritoneal dialysis fluid on ultrafiltration in CAPD. In: La Greca G, ed. Peritoneal dialysis. Milan: Wichtig Editore, 1986:85-6.
16. Niwa T, Katsuzaki T, Miyazaki S, Momoi T, Akiba T, Miyazaki T, et al. Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int 1997; 51:187-94.
17. Anet EFLJ. 3-Deoxyglycosuloses (3-deoxyglucosones) and the degradation of carbohydrates. Adv Carbohydr Chem Biochem 1964; 19:181-219.
18. Weenen H, Tjan SB. Analysis, structure and reactivity of 3-deoxyglucosone. ACS Symp Ser 1992; 490:217-31.
19. Wieslander AP, Deppisch R, Svensson E, Forsbäck G, Speidel R, Rippe B. In vitro biocompatibility of a heat sterilized low-toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1994; 15:158-64.
20. Madson MA, Feather MS. An improved preparation 3-deoxy-D-erythro-hexos-2-ulose via the bis (benzolhydrazone) and some related constitutional studies. Carbohydr Res 1981; 94:183-91.
21. Henle T, Bachmann A. Synthesis of pyrraline. Z Lebensm Unters Forsch 1996; 202:72-5.
22. Yamada H, Miyata S, Igaki N, Yatabe H, Miyauchi Y, Ohara T, et al. Increase in 3-deoxyglucosone levels in diabetic rat plasma. J Biol Chem 1994; 269:20275-80.
23. Sato K, Inazu A, Yamaguchi S, Nakayama T, Deyashiki Y, Sawada H, Hara A. Monkey-deoxyglucosone reductase: Tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase. Arch Biochem Biophys 1993; 307: 286-94.
24. Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD. Perit Dial Int 1995; 15(2):129-33.
25. Mahiout A, Ehlerding G, Brunkhorst R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant 1996; 11:2-6.